SlideShare a Scribd company logo
Viet Nam
Source: Globocan 2020
Summary statistic 2020
Males Females Both sexes
Population 48 598 254 48 740 329 97 338 583
Number of new cancer cases 98 916 83 647 182 563
Age-standardized incidence rate (World) 191.5 135.5 159.7
Risk of developing cancer before the age of 75 years (%) 19.5 13.6 16.3
Number of cancer deaths 74 481 48 209 122 690
Age-standardized mortality rate (World) 144.5 74.8 106.0
Risk of dying from cancer before the age of 75 years (%) 15.0 8.0 11.2
5-year prevalent cases 162 822 191 004 353 826
Top 5 most frequent cancers excluding non-melanoma skin cancer
(ranked by cases)
Liver
Lung
Stomach
Colorectum
Prostate
Breast
Lung
Colorectum
Stomach
Liver
Liver
Lung
Breast
Stomach
Colorectum
Number of new cases in 2020, both sexes, all ages
Total: 182 563
Liver
26 418 (14.5%)
Lung
26 262 (14.4%)
Breast
21 555 (11.8%)
Stomach
17 906 (9.8%)
Colorectum
16 426 (9%)
Other cancers
73 996 (40.5%)
Number of new cases in 2020, males, all ages
Total: 98 916
Liver
20 256 (20.5%)
Lung
18 685 (18.9%)
Stomach
11 059 (11.2%)
Colorectum
8 887 (9%)
Prostate
6 248 (6.3%)
Other cancers
33 781 (34.2%)
Number of new cases in 2020, females, all ages
Total: 83 647
Breast
21 555 (25.8%)
Lung
7 577 (9.1%)
Colorectum
7 539 (9%)
Stomach
6 847 (8.2%)
Liver
6 162 (7.4%)
Other cancers
33 967 (40.6%)
Geography
Numbers at a glance
Total population
97338583
Number of new cases
182563
Number of deaths
122690
Number of prevalent cases (5-year)
353826
Data source and methods
Incidence
Country-specific data source: Hanoi City cancer registry,
Ho Chi Minh City Cancer Registry
Method: Weighted/simple average of the most recent local
rates applied to 2020 population
Mortality
Country-specific data source: National (Survey)
Method: Estimated from national incidence estimates by
modelling, using incidence:mortality ratios derived from
cancer registry data in neighbouring countries
Prevalence
Computed using sex-; site- and age-specific incidence to
1-;3- and 5-year prevalence ratios from Nordic countries for
the period (2006-2015), and scaled using Human
Development Index (HDI) ratios.
The Global Cancer Observatory - All Rights Reserved - March, 2021. Page 1
Viet Nam
Source: Globocan
Incidence, Mortality and Prevalence by cancer site
New cases Deaths 5-year prevalence (all ages)
Cancer Number Rank (%) Cum.risk Number Rank (%) Cum.risk Number Prop. (per 100 000)
Liver 26 418 1 14.5 2.58 25 272 1 20.6 2.47 28 761 29.55
Lung 26 262 2 14.4 2.64 23 797 2 19.4 2.41 28 638 29.42
Breast 21 555 3 11.8 3.69 9 345 4 7.6 1.47 60 753 124.65
Stomach 17 906 4 9.8 1.81 14 615 3 11.9 1.47 23 989 24.64
Rectum 9 399 5 5.1 0.92 4 758 6 3.9 0.41 22 784 23.41
Colon 6 448 6 3.5 0.66 3 445 8 2.8 0.32 14 292 14.68
Leukaemia 6 289 7 3.4 0.52 4 791 5 3.9 0.41 17 010 17.48
Prostate 6 248 8 3.4 1.43 2 628 10 2.1 0.49 10 975 22.58
Nasopharynx 6 040 9 3.3 0.59 3 706 7 3.0 0.39 16 184 16.63
Thyroid 5 471 10 3.0 0.45 642 22 0.52 0.07 16 289 16.73
Corpus uteri 5 354 11 2.9 0.94 1 319 14 1.1 0.25 13 973 28.67
Cervix uteri 4 132 12 2.3 0.70 2 223 12 1.8 0.39 9 999 20.51
Non-Hodgkin lymphoma 3 725 13 2.0 0.36 2 214 13 1.8 0.22 9 804 10.07
Oesophagus 3 281 14 1.8 0.33 3 080 9 2.5 0.31 3 472 3.57
Brain, central nervous system 3 120 15 1.7 0.27 2 614 11 2.1 0.23 8 080 8.30
Kidney 2 435 16 1.3 0.23 1 130 16 0.92 0.11 5 969 6.13
Hypopharynx 2 356 17 1.3 0.24 1 246 15 1.0 0.11 3 458 3.55
Lip, oral cavity 2 152 18 1.2 0.21 1 099 18 0.90 0.11 5 070 5.21
Larynx 2 021 19 1.1 0.21 1 109 17 0.90 0.11 4 996 5.13
Bladder 1 721 20 0.94 0.18 902 21 0.74 0.08 4 292 4.41
Ovary 1 404 21 0.77 0.25 923 20 0.75 0.17 3 468 7.12
Pancreas 1 113 22 0.61 0.11 1 065 19 0.87 0.11 1 055 1.08
Hodgkin lymphoma 651 23 0.36 0.06 251 27 0.20 0.02 1 998 2.05
Oropharynx 605 24 0.33 0.06 306 26 0.25 0.03 1 381 1.42
Anus 579 25 0.32 0.05 321 24 0.26 0.02 1 414 1.45
Multiple myeloma 550 26 0.30 0.06 471 23 0.38 0.05 1 232 1.27
Penis 397 27 0.22 0.09 147 29 0.12 0.03 1 040 2.14
Salivary glands 378 28 0.21 0.04 144 30 0.12 0.01 1 060 1.09
Mesothelioma 356 29 0.20 0.03 306 25 0.25 0.03 431 0.44
Gallbladder 301 30 0.16 0.03 214 28 0.17 0.02 379 0.39
Testis 291 31 0.16 0.05 70 33 0.06 0.01 1 029 2.12
Melanoma of skin 193 32 0.11 0.02 120 31 0.10 0.01 510 0.52
Kaposi sarcoma 172 33 0.09 0.02 101 32 0.08 0.01 423 0.43
Vulva 169 34 0.09 0.02 66 34 0.05 0.01 445 0.91
Vagina 55 35 0.03 0.01 29 35 0.02 0.00 128 0.26
All cancer sites 182 563 - - 16.28 122 690 - - 11.24 353 826 363.5
Age-standardized (World) incidence rates per sex, top 10 cancers
0
10
20
30
40
50 0 10 20 30 40 50
Lung
Liver
Breast
Stomach
Colorectum
Leukaemia
Prostate
Nasopharynx
Thyroid
Corpus uteri
36.8
38.0
21.7
17.6
6.5
12.2
8.1
1.9
11.8
9.8
34.2
10.6
11.6
5.9
2.8
7.6
8.9
ASR (World) per 100 000
Males Females
Age-standardized (World) incidence and mortality rates, top 10 cancers
0
10
20
30
40 0 10 20 30 40
Breast
Liver
Lung
Stomach
Colorectum
Prostate
Corpus uteri
Cervix uteri
Leukaemia
Nasopharynx
34.2
23.0
22.8
15.5
14.1
12.2
8.9
6.6
6.2
5.3
13.8
21.9
20.6
12.6
7.0
5.1
2.1
3.4
4.5
3.3
ASR (World) per 100 000
Incidence Mortality
The Global Cancer Observatory - All Rights Reserved - March, 2021. Page 2

More Related Content

What's hot

U BUỒNG TRỨNG VÀ THAI KỲ
U BUỒNG TRỨNG VÀ THAI KỲU BUỒNG TRỨNG VÀ THAI KỲ
U BUỒNG TRỨNG VÀ THAI KỲ
SoM
 
Cách đọc phim CT Scanner bụng
Cách đọc phim CT Scanner bụngCách đọc phim CT Scanner bụng
Cách đọc phim CT Scanner bụngNguyễn Hạnh
 
TIẾP CẬN BỆNH NHÂN BÁNG BỤNG
TIẾP CẬN BỆNH NHÂN BÁNG BỤNGTIẾP CẬN BỆNH NHÂN BÁNG BỤNG
TIẾP CẬN BỆNH NHÂN BÁNG BỤNG
SoM
 
PAP SMEAR -PHẾT MỎNG TẾ BÀO CỔ TỬ CUNG TẦM SOÁT UNG THƯ CỔ TỬ CUNG - HỆ THỐNG...
PAP SMEAR -PHẾT MỎNG TẾ BÀO CỔ TỬ CUNG TẦM SOÁT UNG THƯ CỔ TỬ CUNG - HỆ THỐNG...PAP SMEAR -PHẾT MỎNG TẾ BÀO CỔ TỬ CUNG TẦM SOÁT UNG THƯ CỔ TỬ CUNG - HỆ THỐNG...
PAP SMEAR -PHẾT MỎNG TẾ BÀO CỔ TỬ CUNG TẦM SOÁT UNG THƯ CỔ TỬ CUNG - HỆ THỐNG...
SoM
 
ct ngực
ct ngựcct ngực
ct ngực
SoM
 
KỸ THUẬT SINH THIẾT TUYẾN TIỀN LIỆT DƯỚI SỰ HƯỚNG DẪN CỦA SIÊU ÂM QUA NGÃ TRỰ...
KỸ THUẬT SINH THIẾT TUYẾN TIỀN LIỆT DƯỚI SỰ HƯỚNG DẪN CỦA SIÊU ÂM QUA NGÃ TRỰ...KỸ THUẬT SINH THIẾT TUYẾN TIỀN LIỆT DƯỚI SỰ HƯỚNG DẪN CỦA SIÊU ÂM QUA NGÃ TRỰ...
KỸ THUẬT SINH THIẾT TUYẾN TIỀN LIỆT DƯỚI SỰ HƯỚNG DẪN CỦA SIÊU ÂM QUA NGÃ TRỰ...
SoM
 
KHỐI U NGUYÊN BÀO NUÔI - THAI TRỨNG
KHỐI U NGUYÊN BÀO NUÔI - THAI TRỨNGKHỐI U NGUYÊN BÀO NUÔI - THAI TRỨNG
KHỐI U NGUYÊN BÀO NUÔI - THAI TRỨNG
SoM
 
Tiếp cận bệnh nhân buồn nôn nôn ói
Tiếp cận bệnh nhân buồn nôn nôn óiTiếp cận bệnh nhân buồn nôn nôn ói
Tiếp cận bệnh nhân buồn nôn nôn ói
long le xuan
 
Ung thư tuỵ
Ung thư tuỵUng thư tuỵ
Ung thư tuỵHùng Lê
 
K phổi di căn
K phổi di cănK phổi di căn
K phổi di căn
Pham Kiem
 
Sổ tay hướng dẫn điều trị Ung Thư Cổ Tử Cung - ESGO-ESTRO-ESP - Cervical Cancer
Sổ tay hướng dẫn điều trị Ung Thư Cổ Tử Cung - ESGO-ESTRO-ESP - Cervical CancerSổ tay hướng dẫn điều trị Ung Thư Cổ Tử Cung - ESGO-ESTRO-ESP - Cervical Cancer
Sổ tay hướng dẫn điều trị Ung Thư Cổ Tử Cung - ESGO-ESTRO-ESP - Cervical Cancer
Yhoccongdong.com
 
Chẩn đoán và điều trị gan nhiễm mỡ
Chẩn đoán và điều trị gan nhiễm mỡChẩn đoán và điều trị gan nhiễm mỡ
Chẩn đoán và điều trị gan nhiễm mỡ
Ngãidr Trancong
 
CHỈ ĐỊNH TRUYỀN CHẾ PHẨM MÁU
CHỈ ĐỊNH TRUYỀN CHẾ PHẨM MÁUCHỈ ĐỊNH TRUYỀN CHẾ PHẨM MÁU
CHỈ ĐỊNH TRUYỀN CHẾ PHẨM MÁU
Vân Thanh
 
Chẩn đoán siêu âm gan và đường mật
Chẩn đoán siêu âm gan và đường mậtChẩn đoán siêu âm gan và đường mật
Chẩn đoán siêu âm gan và đường mật
Dien Dr
 
BỆNH TĂNG HUYẾT ÁP
BỆNH TĂNG HUYẾT ÁPBỆNH TĂNG HUYẾT ÁP
BỆNH TĂNG HUYẾT ÁP
SoM
 
QUẢN LÝ TIẾT DỊCH ÂM ĐẠO BẤT THƯỜNG VÀ PHẾT MỎNG CỔ TỬ CUNG BẤT THƯỜNG BIỂU H...
QUẢN LÝ TIẾT DỊCH ÂM ĐẠO BẤT THƯỜNG VÀ PHẾT MỎNG CỔ TỬ CUNG BẤT THƯỜNG BIỂU H...QUẢN LÝ TIẾT DỊCH ÂM ĐẠO BẤT THƯỜNG VÀ PHẾT MỎNG CỔ TỬ CUNG BẤT THƯỜNG BIỂU H...
QUẢN LÝ TIẾT DỊCH ÂM ĐẠO BẤT THƯỜNG VÀ PHẾT MỎNG CỔ TỬ CUNG BẤT THƯỜNG BIỂU H...
SoM
 
UNG THƯ BUỒNG TRỨNG
UNG THƯ BUỒNG TRỨNGUNG THƯ BUỒNG TRỨNG
UNG THƯ BUỒNG TRỨNG
SoM
 
Đánh giá điều trị đau
Đánh giá điều trị đauĐánh giá điều trị đau
Đánh giá điều trị đau
Thanh Liem Vo
 
TỈ LỆ ĐIỀU TRỊ THUỐC KHÁNG ĐÔNG THEO THANG ĐIỂM CHA2DS2-VAS Ở NGƯỜI CAO TUỔI ...
TỈ LỆ ĐIỀU TRỊ THUỐC KHÁNG ĐÔNG THEO THANG ĐIỂM CHA2DS2-VAS Ở NGƯỜI CAO TUỔI ...TỈ LỆ ĐIỀU TRỊ THUỐC KHÁNG ĐÔNG THEO THANG ĐIỂM CHA2DS2-VAS Ở NGƯỜI CAO TUỔI ...
TỈ LỆ ĐIỀU TRỊ THUỐC KHÁNG ĐÔNG THEO THANG ĐIỂM CHA2DS2-VAS Ở NGƯỜI CAO TUỔI ...
SoM
 

What's hot (20)

U BUỒNG TRỨNG VÀ THAI KỲ
U BUỒNG TRỨNG VÀ THAI KỲU BUỒNG TRỨNG VÀ THAI KỲ
U BUỒNG TRỨNG VÀ THAI KỲ
 
Cách đọc phim CT Scanner bụng
Cách đọc phim CT Scanner bụngCách đọc phim CT Scanner bụng
Cách đọc phim CT Scanner bụng
 
TIẾP CẬN BỆNH NHÂN BÁNG BỤNG
TIẾP CẬN BỆNH NHÂN BÁNG BỤNGTIẾP CẬN BỆNH NHÂN BÁNG BỤNG
TIẾP CẬN BỆNH NHÂN BÁNG BỤNG
 
PAP SMEAR -PHẾT MỎNG TẾ BÀO CỔ TỬ CUNG TẦM SOÁT UNG THƯ CỔ TỬ CUNG - HỆ THỐNG...
PAP SMEAR -PHẾT MỎNG TẾ BÀO CỔ TỬ CUNG TẦM SOÁT UNG THƯ CỔ TỬ CUNG - HỆ THỐNG...PAP SMEAR -PHẾT MỎNG TẾ BÀO CỔ TỬ CUNG TẦM SOÁT UNG THƯ CỔ TỬ CUNG - HỆ THỐNG...
PAP SMEAR -PHẾT MỎNG TẾ BÀO CỔ TỬ CUNG TẦM SOÁT UNG THƯ CỔ TỬ CUNG - HỆ THỐNG...
 
ct ngực
ct ngựcct ngực
ct ngực
 
KỸ THUẬT SINH THIẾT TUYẾN TIỀN LIỆT DƯỚI SỰ HƯỚNG DẪN CỦA SIÊU ÂM QUA NGÃ TRỰ...
KỸ THUẬT SINH THIẾT TUYẾN TIỀN LIỆT DƯỚI SỰ HƯỚNG DẪN CỦA SIÊU ÂM QUA NGÃ TRỰ...KỸ THUẬT SINH THIẾT TUYẾN TIỀN LIỆT DƯỚI SỰ HƯỚNG DẪN CỦA SIÊU ÂM QUA NGÃ TRỰ...
KỸ THUẬT SINH THIẾT TUYẾN TIỀN LIỆT DƯỚI SỰ HƯỚNG DẪN CỦA SIÊU ÂM QUA NGÃ TRỰ...
 
KHỐI U NGUYÊN BÀO NUÔI - THAI TRỨNG
KHỐI U NGUYÊN BÀO NUÔI - THAI TRỨNGKHỐI U NGUYÊN BÀO NUÔI - THAI TRỨNG
KHỐI U NGUYÊN BÀO NUÔI - THAI TRỨNG
 
Tiếp cận bệnh nhân buồn nôn nôn ói
Tiếp cận bệnh nhân buồn nôn nôn óiTiếp cận bệnh nhân buồn nôn nôn ói
Tiếp cận bệnh nhân buồn nôn nôn ói
 
Ung thư tuỵ
Ung thư tuỵUng thư tuỵ
Ung thư tuỵ
 
K phổi di căn
K phổi di cănK phổi di căn
K phổi di căn
 
Sổ tay hướng dẫn điều trị Ung Thư Cổ Tử Cung - ESGO-ESTRO-ESP - Cervical Cancer
Sổ tay hướng dẫn điều trị Ung Thư Cổ Tử Cung - ESGO-ESTRO-ESP - Cervical CancerSổ tay hướng dẫn điều trị Ung Thư Cổ Tử Cung - ESGO-ESTRO-ESP - Cervical Cancer
Sổ tay hướng dẫn điều trị Ung Thư Cổ Tử Cung - ESGO-ESTRO-ESP - Cervical Cancer
 
Chẩn đoán và điều trị gan nhiễm mỡ
Chẩn đoán và điều trị gan nhiễm mỡChẩn đoán và điều trị gan nhiễm mỡ
Chẩn đoán và điều trị gan nhiễm mỡ
 
CHỈ ĐỊNH TRUYỀN CHẾ PHẨM MÁU
CHỈ ĐỊNH TRUYỀN CHẾ PHẨM MÁUCHỈ ĐỊNH TRUYỀN CHẾ PHẨM MÁU
CHỈ ĐỊNH TRUYỀN CHẾ PHẨM MÁU
 
Chẩn đoán siêu âm gan và đường mật
Chẩn đoán siêu âm gan và đường mậtChẩn đoán siêu âm gan và đường mật
Chẩn đoán siêu âm gan và đường mật
 
BỆNH TĂNG HUYẾT ÁP
BỆNH TĂNG HUYẾT ÁPBỆNH TĂNG HUYẾT ÁP
BỆNH TĂNG HUYẾT ÁP
 
QUẢN LÝ TIẾT DỊCH ÂM ĐẠO BẤT THƯỜNG VÀ PHẾT MỎNG CỔ TỬ CUNG BẤT THƯỜNG BIỂU H...
QUẢN LÝ TIẾT DỊCH ÂM ĐẠO BẤT THƯỜNG VÀ PHẾT MỎNG CỔ TỬ CUNG BẤT THƯỜNG BIỂU H...QUẢN LÝ TIẾT DỊCH ÂM ĐẠO BẤT THƯỜNG VÀ PHẾT MỎNG CỔ TỬ CUNG BẤT THƯỜNG BIỂU H...
QUẢN LÝ TIẾT DỊCH ÂM ĐẠO BẤT THƯỜNG VÀ PHẾT MỎNG CỔ TỬ CUNG BẤT THƯỜNG BIỂU H...
 
UNG THƯ BUỒNG TRỨNG
UNG THƯ BUỒNG TRỨNGUNG THƯ BUỒNG TRỨNG
UNG THƯ BUỒNG TRỨNG
 
CT trong chẩn đoán viêm tụy cấp- Công Thiện Y 2005
CT trong chẩn đoán viêm tụy cấp- Công Thiện Y 2005CT trong chẩn đoán viêm tụy cấp- Công Thiện Y 2005
CT trong chẩn đoán viêm tụy cấp- Công Thiện Y 2005
 
Đánh giá điều trị đau
Đánh giá điều trị đauĐánh giá điều trị đau
Đánh giá điều trị đau
 
TỈ LỆ ĐIỀU TRỊ THUỐC KHÁNG ĐÔNG THEO THANG ĐIỂM CHA2DS2-VAS Ở NGƯỜI CAO TUỔI ...
TỈ LỆ ĐIỀU TRỊ THUỐC KHÁNG ĐÔNG THEO THANG ĐIỂM CHA2DS2-VAS Ở NGƯỜI CAO TUỔI ...TỈ LỆ ĐIỀU TRỊ THUỐC KHÁNG ĐÔNG THEO THANG ĐIỂM CHA2DS2-VAS Ở NGƯỜI CAO TUỔI ...
TỈ LỆ ĐIỀU TRỊ THUỐC KHÁNG ĐÔNG THEO THANG ĐIỂM CHA2DS2-VAS Ở NGƯỜI CAO TUỔI ...
 

Similar to Globocan 2020 Viet Nam.pdf

Solid Cancers: An Introduction - Slide 1 - G. Gatta - Rare cancers: frequency...
Solid Cancers: An Introduction - Slide 1 - G. Gatta - Rare cancers: frequency...Solid Cancers: An Introduction - Slide 1 - G. Gatta - Rare cancers: frequency...
Solid Cancers: An Introduction - Slide 1 - G. Gatta - Rare cancers: frequency...European School of Oncology
 
Cancer Epidemiology part I
Cancer Epidemiology part ICancer Epidemiology part I
Cancer Epidemiology part I
Tarek Tawfik Amin
 
HCC in the Arab World Final
 HCC in the Arab World Final HCC in the Arab World Final
HCC in the Arab World Final
PAIRS WEB
 
Catalyzing Growth in the Global Breast Cancer Therapeutics Market
Catalyzing Growth in the Global Breast Cancer Therapeutics MarketCatalyzing Growth in the Global Breast Cancer Therapeutics Market
Catalyzing Growth in the Global Breast Cancer Therapeutics Market
Insights10
 
Global Breast Cancer Therapeutics Market Article
Global Breast Cancer Therapeutics Market ArticleGlobal Breast Cancer Therapeutics Market Article
Global Breast Cancer Therapeutics Market Article
Insights10
 
Impact of covid 19 vaccination on reduction of covid-19 cases and deaths duri...
Impact of covid 19 vaccination on reduction of covid-19 cases and deaths duri...Impact of covid 19 vaccination on reduction of covid-19 cases and deaths duri...
Impact of covid 19 vaccination on reduction of covid-19 cases and deaths duri...
Bhoj Raj Singh
 
Ward statistics 2012 2013
Ward statistics 2012 2013Ward statistics 2012 2013
Ward statistics 2012 2013Muhammad Zafar
 
Lagos 6 10 Nov 2018 Soehpon Conf Global, African, Nigerian Occupational Healt...
Lagos 6 10 Nov 2018 Soehpon Conf Global, African, Nigerian Occupational Healt...Lagos 6 10 Nov 2018 Soehpon Conf Global, African, Nigerian Occupational Healt...
Lagos 6 10 Nov 2018 Soehpon Conf Global, African, Nigerian Occupational Healt...
Jukka Takala
 
Sustainable development goals in the Eastern Mediterranean Region
Sustainable development goals in the Eastern Mediterranean RegionSustainable development goals in the Eastern Mediterranean Region
Sustainable development goals in the Eastern Mediterranean Region
WHO Regional Office for the Eastern Mediterranean
 
Global Facts And Figures 2007 Rev2
Global Facts And Figures 2007 Rev2Global Facts And Figures 2007 Rev2
Global Facts And Figures 2007 Rev2
Andrew Kwami
 
healthcare healthcare statistics.pdf
healthcare healthcare statistics.pdfhealthcare healthcare statistics.pdf
healthcare healthcare statistics.pdf
sdfghj21
 
Los países más saludables
Los países más saludablesLos países más saludables
Los países más saludables
Luis Noguera
 
Biostatistics of heart diseases in Egypt
Biostatistics of heart diseases in EgyptBiostatistics of heart diseases in Egypt
Biostatistics of heart diseases in Egypt
Mohamed Kamal
 
Non-communicable Diseases
Non-communicable DiseasesNon-communicable Diseases
Non-communicable Diseases
晓飞 冯
 
HDI and cancer
 HDI and cancer HDI and cancer
HDI and cancer
sajalmondal9
 
Kshivets astana wscts2017
Kshivets astana wscts2017Kshivets astana wscts2017
Kshivets astana wscts2017
Oleg Kshivets
 
Strengthening vital statistics in Brazil: investigation of ill-defined causes...
Strengthening vital statistics in Brazil: investigation of ill-defined causes...Strengthening vital statistics in Brazil: investigation of ill-defined causes...
Strengthening vital statistics in Brazil: investigation of ill-defined causes...
Institute for Health Metrics and Evaluation - University of Washington
 
2022-World-Population-Data-Sheet-Booklet.pdf
2022-World-Population-Data-Sheet-Booklet.pdf2022-World-Population-Data-Sheet-Booklet.pdf
2022-World-Population-Data-Sheet-Booklet.pdf
RavendraSharma6
 
Soft tissue Sarcoma Market
Soft tissue Sarcoma MarketSoft tissue Sarcoma Market
Soft tissue Sarcoma Market
Dr. B.K. Agrawal
 

Similar to Globocan 2020 Viet Nam.pdf (20)

Solid Cancers: An Introduction - Slide 1 - G. Gatta - Rare cancers: frequency...
Solid Cancers: An Introduction - Slide 1 - G. Gatta - Rare cancers: frequency...Solid Cancers: An Introduction - Slide 1 - G. Gatta - Rare cancers: frequency...
Solid Cancers: An Introduction - Slide 1 - G. Gatta - Rare cancers: frequency...
 
Cancer Epidemiology part I
Cancer Epidemiology part ICancer Epidemiology part I
Cancer Epidemiology part I
 
HCC in the Arab World Final
 HCC in the Arab World Final HCC in the Arab World Final
HCC in the Arab World Final
 
Catalyzing Growth in the Global Breast Cancer Therapeutics Market
Catalyzing Growth in the Global Breast Cancer Therapeutics MarketCatalyzing Growth in the Global Breast Cancer Therapeutics Market
Catalyzing Growth in the Global Breast Cancer Therapeutics Market
 
Global Breast Cancer Therapeutics Market Article
Global Breast Cancer Therapeutics Market ArticleGlobal Breast Cancer Therapeutics Market Article
Global Breast Cancer Therapeutics Market Article
 
Impact of covid 19 vaccination on reduction of covid-19 cases and deaths duri...
Impact of covid 19 vaccination on reduction of covid-19 cases and deaths duri...Impact of covid 19 vaccination on reduction of covid-19 cases and deaths duri...
Impact of covid 19 vaccination on reduction of covid-19 cases and deaths duri...
 
Ward statistics 2012 2013
Ward statistics 2012 2013Ward statistics 2012 2013
Ward statistics 2012 2013
 
Lagos 6 10 Nov 2018 Soehpon Conf Global, African, Nigerian Occupational Healt...
Lagos 6 10 Nov 2018 Soehpon Conf Global, African, Nigerian Occupational Healt...Lagos 6 10 Nov 2018 Soehpon Conf Global, African, Nigerian Occupational Healt...
Lagos 6 10 Nov 2018 Soehpon Conf Global, African, Nigerian Occupational Healt...
 
Sustainable development goals in the Eastern Mediterranean Region
Sustainable development goals in the Eastern Mediterranean RegionSustainable development goals in the Eastern Mediterranean Region
Sustainable development goals in the Eastern Mediterranean Region
 
Global Facts And Figures 2007 Rev2
Global Facts And Figures 2007 Rev2Global Facts And Figures 2007 Rev2
Global Facts And Figures 2007 Rev2
 
healthcare healthcare statistics.pdf
healthcare healthcare statistics.pdfhealthcare healthcare statistics.pdf
healthcare healthcare statistics.pdf
 
Los países más saludables
Los países más saludablesLos países más saludables
Los países más saludables
 
Biostatistics of heart diseases in Egypt
Biostatistics of heart diseases in EgyptBiostatistics of heart diseases in Egypt
Biostatistics of heart diseases in Egypt
 
Non-communicable Diseases
Non-communicable DiseasesNon-communicable Diseases
Non-communicable Diseases
 
HDI and cancer
 HDI and cancer HDI and cancer
HDI and cancer
 
Kshivets astana wscts2017
Kshivets astana wscts2017Kshivets astana wscts2017
Kshivets astana wscts2017
 
Final
FinalFinal
Final
 
Strengthening vital statistics in Brazil: investigation of ill-defined causes...
Strengthening vital statistics in Brazil: investigation of ill-defined causes...Strengthening vital statistics in Brazil: investigation of ill-defined causes...
Strengthening vital statistics in Brazil: investigation of ill-defined causes...
 
2022-World-Population-Data-Sheet-Booklet.pdf
2022-World-Population-Data-Sheet-Booklet.pdf2022-World-Population-Data-Sheet-Booklet.pdf
2022-World-Population-Data-Sheet-Booklet.pdf
 
Soft tissue Sarcoma Market
Soft tissue Sarcoma MarketSoft tissue Sarcoma Market
Soft tissue Sarcoma Market
 

More from John Nguyen

Fluid-Balance-Monitoring-Poster.pdf
Fluid-Balance-Monitoring-Poster.pdfFluid-Balance-Monitoring-Poster.pdf
Fluid-Balance-Monitoring-Poster.pdf
John Nguyen
 
Fluid Management for Critically Ill .pdf
Fluid Management for Critically Ill .pdfFluid Management for Critically Ill .pdf
Fluid Management for Critically Ill .pdf
John Nguyen
 
FesslerelecrolytesinPN.pdf
FesslerelecrolytesinPN.pdfFesslerelecrolytesinPN.pdf
FesslerelecrolytesinPN.pdf
John Nguyen
 
Fluid Management in Patients with Chronic Heart Failure (2).pdf
Fluid Management in Patients with Chronic Heart Failure (2).pdfFluid Management in Patients with Chronic Heart Failure (2).pdf
Fluid Management in Patients with Chronic Heart Failure (2).pdf
John Nguyen
 
Fluid Management in Patients with Chronic Heart Failure.pdf
Fluid Management in Patients with Chronic Heart Failure.pdfFluid Management in Patients with Chronic Heart Failure.pdf
Fluid Management in Patients with Chronic Heart Failure.pdf
John Nguyen
 
Oliclionel.pdf
Oliclionel.pdfOliclionel.pdf
Oliclionel.pdf
John Nguyen
 
Hướng-dẫn-dùng-thuốc-trong-Cấp-cứu.pdf
Hướng-dẫn-dùng-thuốc-trong-Cấp-cứu.pdfHướng-dẫn-dùng-thuốc-trong-Cấp-cứu.pdf
Hướng-dẫn-dùng-thuốc-trong-Cấp-cứu.pdf
John Nguyen
 
non-protein-calorie-nitrogen-ratio-npcn-as-a-determinant-7513.pdf
non-protein-calorie-nitrogen-ratio-npcn-as-a-determinant-7513.pdfnon-protein-calorie-nitrogen-ratio-npcn-as-a-determinant-7513.pdf
non-protein-calorie-nitrogen-ratio-npcn-as-a-determinant-7513.pdf
John Nguyen
 
Regimen Nutrition at Ke Sach hospital.pdf
Regimen Nutrition at Ke Sach hospital.pdfRegimen Nutrition at Ke Sach hospital.pdf
Regimen Nutrition at Ke Sach hospital.pdf
John Nguyen
 
2008 Effect of intensive nutrition in gastrointestinal fistula.pdf
2008 Effect of intensive nutrition in gastrointestinal fistula.pdf2008 Effect of intensive nutrition in gastrointestinal fistula.pdf
2008 Effect of intensive nutrition in gastrointestinal fistula.pdf
John Nguyen
 
SBIS_Nutrition_CPG_new_format.pdf
SBIS_Nutrition_CPG_new_format.pdfSBIS_Nutrition_CPG_new_format.pdf
SBIS_Nutrition_CPG_new_format.pdf
John Nguyen
 
Protein energy malnutrition
Protein energy malnutritionProtein energy malnutrition
Protein energy malnutrition
John Nguyen
 
Hepatic encephalopathy
Hepatic encephalopathyHepatic encephalopathy
Hepatic encephalopathy
John Nguyen
 

More from John Nguyen (13)

Fluid-Balance-Monitoring-Poster.pdf
Fluid-Balance-Monitoring-Poster.pdfFluid-Balance-Monitoring-Poster.pdf
Fluid-Balance-Monitoring-Poster.pdf
 
Fluid Management for Critically Ill .pdf
Fluid Management for Critically Ill .pdfFluid Management for Critically Ill .pdf
Fluid Management for Critically Ill .pdf
 
FesslerelecrolytesinPN.pdf
FesslerelecrolytesinPN.pdfFesslerelecrolytesinPN.pdf
FesslerelecrolytesinPN.pdf
 
Fluid Management in Patients with Chronic Heart Failure (2).pdf
Fluid Management in Patients with Chronic Heart Failure (2).pdfFluid Management in Patients with Chronic Heart Failure (2).pdf
Fluid Management in Patients with Chronic Heart Failure (2).pdf
 
Fluid Management in Patients with Chronic Heart Failure.pdf
Fluid Management in Patients with Chronic Heart Failure.pdfFluid Management in Patients with Chronic Heart Failure.pdf
Fluid Management in Patients with Chronic Heart Failure.pdf
 
Oliclionel.pdf
Oliclionel.pdfOliclionel.pdf
Oliclionel.pdf
 
Hướng-dẫn-dùng-thuốc-trong-Cấp-cứu.pdf
Hướng-dẫn-dùng-thuốc-trong-Cấp-cứu.pdfHướng-dẫn-dùng-thuốc-trong-Cấp-cứu.pdf
Hướng-dẫn-dùng-thuốc-trong-Cấp-cứu.pdf
 
non-protein-calorie-nitrogen-ratio-npcn-as-a-determinant-7513.pdf
non-protein-calorie-nitrogen-ratio-npcn-as-a-determinant-7513.pdfnon-protein-calorie-nitrogen-ratio-npcn-as-a-determinant-7513.pdf
non-protein-calorie-nitrogen-ratio-npcn-as-a-determinant-7513.pdf
 
Regimen Nutrition at Ke Sach hospital.pdf
Regimen Nutrition at Ke Sach hospital.pdfRegimen Nutrition at Ke Sach hospital.pdf
Regimen Nutrition at Ke Sach hospital.pdf
 
2008 Effect of intensive nutrition in gastrointestinal fistula.pdf
2008 Effect of intensive nutrition in gastrointestinal fistula.pdf2008 Effect of intensive nutrition in gastrointestinal fistula.pdf
2008 Effect of intensive nutrition in gastrointestinal fistula.pdf
 
SBIS_Nutrition_CPG_new_format.pdf
SBIS_Nutrition_CPG_new_format.pdfSBIS_Nutrition_CPG_new_format.pdf
SBIS_Nutrition_CPG_new_format.pdf
 
Protein energy malnutrition
Protein energy malnutritionProtein energy malnutrition
Protein energy malnutrition
 
Hepatic encephalopathy
Hepatic encephalopathyHepatic encephalopathy
Hepatic encephalopathy
 

Recently uploaded

定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
khvdq584
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
Brian Frerichs
 
PET CT beginners Guide covers some of the underrepresented topics in PET CT
PET CT  beginners Guide  covers some of the underrepresented topics  in PET CTPET CT  beginners Guide  covers some of the underrepresented topics  in PET CT
PET CT beginners Guide covers some of the underrepresented topics in PET CT
MiadAlsulami
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 
karnapuran PPT made by Dr nishant very easy to understand how karanapuran is ...
karnapuran PPT made by Dr nishant very easy to understand how karanapuran is ...karnapuran PPT made by Dr nishant very easy to understand how karanapuran is ...
karnapuran PPT made by Dr nishant very easy to understand how karanapuran is ...
Nishant Taralkar
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
CANSA The Cancer Association of South Africa
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
Azreen Aj
 
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your LifeThe Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
ranishasharma67
 
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsxChild Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Sankalpa Gunathilaka
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
Dinesh Chauhan
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
Radhika kulvi
 
The Importance of Community Nursing Care.pdf
The Importance of Community Nursing Care.pdfThe Importance of Community Nursing Care.pdf
The Importance of Community Nursing Care.pdf
AD Healthcare
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
Iris Thiele Isip-Tan
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 
ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
Pooja Rani
 
The Importance of COVID-19 PCR Tests for Travel in 2024.pptx
The Importance of COVID-19 PCR Tests for Travel in 2024.pptxThe Importance of COVID-19 PCR Tests for Travel in 2024.pptx
The Importance of COVID-19 PCR Tests for Travel in 2024.pptx
Global Travel Clinics
 
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic IllnessesPrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx Program
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
Rajarambapu College of Pharmacy Kasegaon Dist Sangli
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
Rommel Luis III Israel
 

Recently uploaded (20)

定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
 
PET CT beginners Guide covers some of the underrepresented topics in PET CT
PET CT  beginners Guide  covers some of the underrepresented topics  in PET CTPET CT  beginners Guide  covers some of the underrepresented topics  in PET CT
PET CT beginners Guide covers some of the underrepresented topics in PET CT
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 
karnapuran PPT made by Dr nishant very easy to understand how karanapuran is ...
karnapuran PPT made by Dr nishant very easy to understand how karanapuran is ...karnapuran PPT made by Dr nishant very easy to understand how karanapuran is ...
karnapuran PPT made by Dr nishant very easy to understand how karanapuran is ...
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
 
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your LifeThe Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
 
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsxChild Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
 
The Importance of Community Nursing Care.pdf
The Importance of Community Nursing Care.pdfThe Importance of Community Nursing Care.pdf
The Importance of Community Nursing Care.pdf
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 
ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
 
The Importance of COVID-19 PCR Tests for Travel in 2024.pptx
The Importance of COVID-19 PCR Tests for Travel in 2024.pptxThe Importance of COVID-19 PCR Tests for Travel in 2024.pptx
The Importance of COVID-19 PCR Tests for Travel in 2024.pptx
 
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic IllnessesPrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic Illnesses
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
 

Globocan 2020 Viet Nam.pdf

  • 1. Viet Nam Source: Globocan 2020 Summary statistic 2020 Males Females Both sexes Population 48 598 254 48 740 329 97 338 583 Number of new cancer cases 98 916 83 647 182 563 Age-standardized incidence rate (World) 191.5 135.5 159.7 Risk of developing cancer before the age of 75 years (%) 19.5 13.6 16.3 Number of cancer deaths 74 481 48 209 122 690 Age-standardized mortality rate (World) 144.5 74.8 106.0 Risk of dying from cancer before the age of 75 years (%) 15.0 8.0 11.2 5-year prevalent cases 162 822 191 004 353 826 Top 5 most frequent cancers excluding non-melanoma skin cancer (ranked by cases) Liver Lung Stomach Colorectum Prostate Breast Lung Colorectum Stomach Liver Liver Lung Breast Stomach Colorectum Number of new cases in 2020, both sexes, all ages Total: 182 563 Liver 26 418 (14.5%) Lung 26 262 (14.4%) Breast 21 555 (11.8%) Stomach 17 906 (9.8%) Colorectum 16 426 (9%) Other cancers 73 996 (40.5%) Number of new cases in 2020, males, all ages Total: 98 916 Liver 20 256 (20.5%) Lung 18 685 (18.9%) Stomach 11 059 (11.2%) Colorectum 8 887 (9%) Prostate 6 248 (6.3%) Other cancers 33 781 (34.2%) Number of new cases in 2020, females, all ages Total: 83 647 Breast 21 555 (25.8%) Lung 7 577 (9.1%) Colorectum 7 539 (9%) Stomach 6 847 (8.2%) Liver 6 162 (7.4%) Other cancers 33 967 (40.6%) Geography Numbers at a glance Total population 97338583 Number of new cases 182563 Number of deaths 122690 Number of prevalent cases (5-year) 353826 Data source and methods Incidence Country-specific data source: Hanoi City cancer registry, Ho Chi Minh City Cancer Registry Method: Weighted/simple average of the most recent local rates applied to 2020 population Mortality Country-specific data source: National (Survey) Method: Estimated from national incidence estimates by modelling, using incidence:mortality ratios derived from cancer registry data in neighbouring countries Prevalence Computed using sex-; site- and age-specific incidence to 1-;3- and 5-year prevalence ratios from Nordic countries for the period (2006-2015), and scaled using Human Development Index (HDI) ratios. The Global Cancer Observatory - All Rights Reserved - March, 2021. Page 1
  • 2. Viet Nam Source: Globocan Incidence, Mortality and Prevalence by cancer site New cases Deaths 5-year prevalence (all ages) Cancer Number Rank (%) Cum.risk Number Rank (%) Cum.risk Number Prop. (per 100 000) Liver 26 418 1 14.5 2.58 25 272 1 20.6 2.47 28 761 29.55 Lung 26 262 2 14.4 2.64 23 797 2 19.4 2.41 28 638 29.42 Breast 21 555 3 11.8 3.69 9 345 4 7.6 1.47 60 753 124.65 Stomach 17 906 4 9.8 1.81 14 615 3 11.9 1.47 23 989 24.64 Rectum 9 399 5 5.1 0.92 4 758 6 3.9 0.41 22 784 23.41 Colon 6 448 6 3.5 0.66 3 445 8 2.8 0.32 14 292 14.68 Leukaemia 6 289 7 3.4 0.52 4 791 5 3.9 0.41 17 010 17.48 Prostate 6 248 8 3.4 1.43 2 628 10 2.1 0.49 10 975 22.58 Nasopharynx 6 040 9 3.3 0.59 3 706 7 3.0 0.39 16 184 16.63 Thyroid 5 471 10 3.0 0.45 642 22 0.52 0.07 16 289 16.73 Corpus uteri 5 354 11 2.9 0.94 1 319 14 1.1 0.25 13 973 28.67 Cervix uteri 4 132 12 2.3 0.70 2 223 12 1.8 0.39 9 999 20.51 Non-Hodgkin lymphoma 3 725 13 2.0 0.36 2 214 13 1.8 0.22 9 804 10.07 Oesophagus 3 281 14 1.8 0.33 3 080 9 2.5 0.31 3 472 3.57 Brain, central nervous system 3 120 15 1.7 0.27 2 614 11 2.1 0.23 8 080 8.30 Kidney 2 435 16 1.3 0.23 1 130 16 0.92 0.11 5 969 6.13 Hypopharynx 2 356 17 1.3 0.24 1 246 15 1.0 0.11 3 458 3.55 Lip, oral cavity 2 152 18 1.2 0.21 1 099 18 0.90 0.11 5 070 5.21 Larynx 2 021 19 1.1 0.21 1 109 17 0.90 0.11 4 996 5.13 Bladder 1 721 20 0.94 0.18 902 21 0.74 0.08 4 292 4.41 Ovary 1 404 21 0.77 0.25 923 20 0.75 0.17 3 468 7.12 Pancreas 1 113 22 0.61 0.11 1 065 19 0.87 0.11 1 055 1.08 Hodgkin lymphoma 651 23 0.36 0.06 251 27 0.20 0.02 1 998 2.05 Oropharynx 605 24 0.33 0.06 306 26 0.25 0.03 1 381 1.42 Anus 579 25 0.32 0.05 321 24 0.26 0.02 1 414 1.45 Multiple myeloma 550 26 0.30 0.06 471 23 0.38 0.05 1 232 1.27 Penis 397 27 0.22 0.09 147 29 0.12 0.03 1 040 2.14 Salivary glands 378 28 0.21 0.04 144 30 0.12 0.01 1 060 1.09 Mesothelioma 356 29 0.20 0.03 306 25 0.25 0.03 431 0.44 Gallbladder 301 30 0.16 0.03 214 28 0.17 0.02 379 0.39 Testis 291 31 0.16 0.05 70 33 0.06 0.01 1 029 2.12 Melanoma of skin 193 32 0.11 0.02 120 31 0.10 0.01 510 0.52 Kaposi sarcoma 172 33 0.09 0.02 101 32 0.08 0.01 423 0.43 Vulva 169 34 0.09 0.02 66 34 0.05 0.01 445 0.91 Vagina 55 35 0.03 0.01 29 35 0.02 0.00 128 0.26 All cancer sites 182 563 - - 16.28 122 690 - - 11.24 353 826 363.5 Age-standardized (World) incidence rates per sex, top 10 cancers 0 10 20 30 40 50 0 10 20 30 40 50 Lung Liver Breast Stomach Colorectum Leukaemia Prostate Nasopharynx Thyroid Corpus uteri 36.8 38.0 21.7 17.6 6.5 12.2 8.1 1.9 11.8 9.8 34.2 10.6 11.6 5.9 2.8 7.6 8.9 ASR (World) per 100 000 Males Females Age-standardized (World) incidence and mortality rates, top 10 cancers 0 10 20 30 40 0 10 20 30 40 Breast Liver Lung Stomach Colorectum Prostate Corpus uteri Cervix uteri Leukaemia Nasopharynx 34.2 23.0 22.8 15.5 14.1 12.2 8.9 6.6 6.2 5.3 13.8 21.9 20.6 12.6 7.0 5.1 2.1 3.4 4.5 3.3 ASR (World) per 100 000 Incidence Mortality The Global Cancer Observatory - All Rights Reserved - March, 2021. Page 2